Cadian Capital Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-100,665
| Closed | -$2.09M | – | 53 |
|
|
2016
Q4 | $2.09M | Sell |
100,665
-140,000
| -58% | -$2.91M | 0.11% | 40 |
|
|
2016
Q3 | $7.89M | Sell |
240,665
-376,200
| -61% | -$12.3M | 0.42% | 39 |
|
|
2016
Q2 | $15.4M | Buy |
616,865
+530,000
| +610% | +$13.2M | 0.85% | 29 |
|
|
2016
Q1 | $2.13M | Sell |
86,865
-302,835
| -78% | -$7.42M | 0.14% | 47 |
|
|
2015
Q4 | $12.9M | Hold |
389,700
| – | – | 0.46% | 49 |
|
|
2015
Q3 | $12.8M | Sell |
389,700
-35,300
| -8% | -$1.16M | 0.46% | 52 |
|
|
2015
Q2 | $22.5M | Buy |
425,000
+370,000
| +673% | +$19.6M | 0.66% | 33 |
|
|
2015
Q1 | $1.59M | Buy |
+55,000
| New | +$1.59M | 0.04% | 69 |
|
|
2014
Q4 | – | Sell |
-120,000
| Closed | -$1.52M | – | 104 |
|
|
2014
Q3 | $1.52M | Buy |
120,000
+20,000
| +20% | +$254K | 0.04% | 75 |
|
|
2014
Q2 | $2.01M | Buy |
+100,000
| New | +$2.01M | 0.06% | 65 |
|